Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

Also called NCT03882775

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03882775
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03882775. Randomized; single masking; primary purpose treatment. Start 2019-01-16 (actual); primary completion 2020-07-14 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction
Acronym
BEST
Condition
STEMI
Condition
Aged
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Heparin
Lead sponsor
The First Affiliated Hospital of Dalian Medical University (class: other)
Collaborator
Beijing Friendship Hospital (class: other)

Record details

Record id
cardio:ct-nct03882775
Content hash
2e52925d8c7241d30acf1e8bd817bf658fca36cfbf971455480a9833eb03a796